Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Gulati

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Cancer|May 19, 2012
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declinesRuth Etzioni, Roman Gulati, Alex Tsodikov, et al.
The Prostate|March 14, 2019
Clinical determinants for successful circulating tumor DNA analysis in prostate cancerMichael T Schweizer, Roman Gulati, Mallory Beightol, et al.
International Journal of Cancer|October 11, 2023
Benefits and harms of prostate specific antigen testing according to Australian guidelinesMichael Caruana, Roman Gulati, Ruth Etzioni, et al.
Human Pathology|October 29, 2022
Clonal relationships of adjacent Gleason pattern 3 and Gleason pattern 5 lesions in Gleason Scores 3+5=8 and 5+3=8Hasim Bakbak, Erolcan Sayar, Harsimar B Kaur, et al.
The Annals of Applied Statistics|January 11, 2019
ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLSJane M Lange, Roman Gulati, Amy S Leonardson, et al.
European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.
Plos One|September 30, 2020
Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancerAlexander S Carlson, Rigo I Acevedo, Daniel M Lim, et al.
BMC Molecular Biology|February 19, 2013
Single cell transcriptomic analysis of prostate cancer cellsChristopher J Welty, Ilsa Coleman, Roger Coleman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 7, 2011
What if I don't treat my PSA-detected prostate cancer? Answers from three natural history modelsRoman Gulati, Elisabeth M Wever, Alex Tsodikov, et al.
The Journal of Clinical Investigation|June 25, 2026
Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander B Frank, Ruth Dumpit, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Cancer|May 19, 2012
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declinesRuth Etzioni, Roman Gulati, Alex Tsodikov, et al.
The Prostate|March 14, 2019
Clinical determinants for successful circulating tumor DNA analysis in prostate cancerMichael T Schweizer, Roman Gulati, Mallory Beightol, et al.
International Journal of Cancer|October 11, 2023
Benefits and harms of prostate specific antigen testing according to Australian guidelinesMichael Caruana, Roman Gulati, Ruth Etzioni, et al.
Human Pathology|October 29, 2022
Clonal relationships of adjacent Gleason pattern 3 and Gleason pattern 5 lesions in Gleason Scores 3+5=8 and 5+3=8Hasim Bakbak, Erolcan Sayar, Harsimar B Kaur, et al.
The Annals of Applied Statistics|January 11, 2019
ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLSJane M Lange, Roman Gulati, Amy S Leonardson, et al.
European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.
Plos One|September 30, 2020
Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancerAlexander S Carlson, Rigo I Acevedo, Daniel M Lim, et al.
BMC Molecular Biology|February 19, 2013
Single cell transcriptomic analysis of prostate cancer cellsChristopher J Welty, Ilsa Coleman, Roger Coleman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 7, 2011
What if I don't treat my PSA-detected prostate cancer? Answers from three natural history modelsRoman Gulati, Elisabeth M Wever, Alex Tsodikov, et al.
The Journal of Clinical Investigation|June 25, 2026
Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander B Frank, Ruth Dumpit, et al.
Pageof 16